Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ABIOMED Company Profile (NASDAQ:ABMD)

Consensus Ratings for ABIOMED (NASDAQ:ABMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $35.00 (2.37% downside)

Analysts' Ratings History for ABIOMED (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/20/2014ZacksReiterated RatingNeutral -> Neutral$36.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
11/3/2014BTIG ResearchDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
8/5/2014ZacksReiterated RatingNeutral -> Neutral$27.00ViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Leerink SwannInitiated CoverageOutperform$34.00ViewTweet This Rating  Share This Rating on StockTwits
3/21/2014BTIG ResearchUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
2/20/2014BTIG ResearchInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
1/10/2014WunderlichBoost Price TargetBuy$29.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
11/10/2013Benchmark Co.Reiterated RatingBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2013Northland Capital PartnersBoost Price TargetUnderperform$9.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013Benchmark Co.Initiated CoverageSpeculative Buy -> Buy$25.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2013TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
4/9/2013Piper JaffrayDowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/15/2013William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/13/2013William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Northland SecuritiesReiterated RatingUnderperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/17/2012 forward)